Why is Vaishali Pharma falling/rising?

As of 16-Sep, Vaishali Pharma Ltd is currently priced at 12.04, reflecting a slight increase of 0.01 or 0.08%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its price performance. Despite a recent rise in investor participation, with delivery volume increasing by 177.02% against the 5-day average, the stock has shown poor performance over various time frames, including a year-to-date decline of 31.16% and a one-year drop of 39.15%. The company's fundamentals are weak, highlighted by a significant -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which raises concerns about its long-term viability.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.49% over the past week and 2.47% over the past month. This underperformance is compounded by the company's flat results reported in June, where profit after tax fell by 24.7%. The weak ability to service debt, as indicated by a poor EBIT to Interest ratio of 1.68, further exacerbates the stock's risk profile. Overall, while there has been a minor uptick in the stock price, the underlying fundamentals and market conditions suggest a challenging environment for Vaishali Pharma Ltd.